Source: Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, Stefan Niemann, Emmanuel André, Michel K. Kaswa, Elisa Tagliani, Andrea Cabibbe, Vanessa Mathys, Daniela Cirillo, Bouke C. de Jong, Leen Rigouts, Philip Supply. Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs. Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020

Member's Comments

No comment yet.

Related content which might interest you: Application of next-generation sequencing to detect MTB resistance to first- and second-line anti-TB drugs Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Identification of isoniazid mono-resistance is delayed despite whole genome sequencing Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS) Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Development of real-time PCR technique for detection of the M.tuberculosis DNA mutations associated with fluoroquinolones drug resistance Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB Source: Eur Respir J, 57 (1) 2001796; 10.1183/13993003.01796-2020 Year: 2021 Detection of rifampin resistance mutations in Mycobacterium tuberculosis by use of sequencing, molecular beacons and taqman probes Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Risk factors of development of amplified Mtb resistance to antituberculous drugs Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Detection of isoniazid resistance mutations in Mycobacterium tuberculosis by use of sequencing, PCR-RFLP and TaqMan probes Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 The use of the lytic D29 mycobacteriophages for accelerated determination of the drug sensitivity of tuberculosis mycobacteria to first and second-line anti-TB drugs in clinical isolates obtained after initial cultivation Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020 Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay Source: Eur Respir J 2013; 41: 1163-1171 Year: 2013 The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Treatment efficacy of MDR TB based on drug susceptibility testing with microchip technology Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4)  1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017 Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005